文献速递神经骨肌介入MRDSA

时间分辨对比增强磁共振血管成像在富血供脊柱转移瘤栓塞前的可靠性与准确性

Reliability and accuracy of time-resolved contrast-enhanced magnetic resonance angiography in hypervascular spinal metastases prior embolization.
PubMed 文献 · Eur Radiol · 2021-01-15

前瞻性纳入2016至2019年间因富血供脊柱转移瘤拟行术前栓塞的连续患者30例共55个椎体水平,比较时间分辨对比增强磁共振血管成像(TR-CE-MRA)与选择性动脉数字减影血管造影(IA-DSA)评估肿瘤血供丰富程度及脊髓动脉供血的一致性,TR-CE-MRA区分富血供与非富血供转移瘤的敏感度为97.9%、特异度为71.4%、准确率为94.6%,但仅2/30例(6.7%)可评估脊髓动脉供血且观察者间无一致性。

要点

  • TR-CE-MRA区分富血供与非富血供脊柱转移瘤的敏感度为97.9%、特异度为71.4%、准确率为94.6%。
  • TR-CE-MRA与IA-DSA的模态间一致性良好(κ=0.74),观察者间一致性中等(κ=0.52)。
  • TR-CE-MRA仅2/30例(6.7%)可评估脊髓动脉供血且观察者间无一致性(κ<0)。

核心结论

  • TR-CE-MRA能可靠区分富血供与非富血供脊柱转移瘤,从而避免无效的IA-DSA。
  • TR-CE-MRA无法评估目标水平的脊髓动脉供血,限制了其作为治疗前评估工具的应用范围。

研究设计与样本

  • 前瞻性纳入所有因富血供脊柱转移瘤转诊行术前栓塞的连续患者,共30例、55个椎体水平,纳入时间为2016至2019年。
  • 栓塞前完成TR-CE-MRA序列与选择性IA-DSA检查。
  • 两名阅片者独立评估影像数据,采用3级分级与二分法(是 vs 否)评估肿瘤血供丰富程度,并识别脊髓动脉供血。
  • 采用kappa统计量评估观察者间与模态间一致性。

诊断标准与关键数值

  • TR-CE-MRA区分富血供与非富血供脊柱转移瘤的敏感度为97.9%、特异度为71.4%、阳性预测值为95.9%、阴性预测值为83.3%、总体准确率为94.6%。
  • TR-CE-MRA观察者间一致性中等(κ=0.52;95%CI 0.09-0.81)。
  • TR-CE-MRA与IA-DSA模态间一致性良好(κ=0.74;95%CI 0.37-1.00)。
  • 脊髓动脉供血在2/30例(6.7%)中可评估,观察者间无一致性(κ<0)。

临床应用与阅片要点

  • TR-CE-MRA可用于区分富血供与非富血供脊柱转移瘤,避免无效的IA-DSA。
  • TR-CE-MRA空间分辨率不足以替代IA-DSA进行脊髓血管解剖的治疗前评估。

局限性

  • TR-CE-MRA无法评估目标水平的脊髓动脉供血,从而限制其作为治疗前评估工具的应用范围。
  • TR-CE-MRA的空间分辨率不足以替代IA-DSA进行脊髓血管解剖的治疗前评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Preoperative embolization of hypervascular spinal metastases (HSM) is efficient to reduce perioperative bleeding. However, intra-arterial digital subtraction angiography (IA-DSA) must confirm the hypervascular nature and rule out spinal cord arterial feeders. This study aimed to evaluate the reliability and accuracy of time-resolved contrast-enhanced magnetic resonance angiography (TR-CE-MRA) in assessing HSM prior to embolization.

METHODS: All consecutive patients referred for preoperative embolization of an HSM were prospectively included. TR-CE-MRA sequences and selective IA-DSA were performed prior to embolization. Two readers independently reviewed imaging data to grade tumor vascularity (using a 3-grade and a dichotomized "yes vs no" scale) and identify the arterial supply of the spinal cord. Interobserver and intermodality agreements were estimated using kappa statistics.

RESULTS: Thirty patients included between 2016 and 2019 were assessed for 55 levels. Interobserver agreement was moderate (κ = 0.52; 95% CI [0.09-0.81]) for TR-CE-MRA. Intermodality agreement between TR-CE-MRA and IA-DSA was good (κ = 0.74; 95% CI [0.37-1.00]). TR-CE-MRA had a sensitivity of 97.9%, a specificity of 71.4%, a positive predictive value of 95.9%, a negative predictive value of 83.3%, and an overall accuracy of 94.6%, for differentiating hypervascular from non-hypervascular SM. The arterial supply of the spine was assessable in 2/30 (6.7%) cases with no interobserver agreement (κ < 0).

CONCLUSIONS: TR-CE-MRA can reliably differentiate hypervascular from non-hypervascular SM and thereby avoid futile IA-DSAs. However, TR-CE-MRA was not able to evaluate the vascular supply of the spinal cord at the target levels, thus limiting its scope as a pretherapeutic assessment tool.

KEY POINTS: • TR-CE-MRA aids in distinguishing hypervascular from non-hypervascular spinal metastases. • TR-CE-MRA could avoid one-quarter of patients referred for HSM embolization to undergo futile conventional angiography. • TR-CE-MRA's spatial resolution is insufficient to replace IA-DSA in the pretherapeutic assessment of the spinal cord vascular anatomy.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Premat K, Shotar E, Burns R, et al. Reliability and accuracy of time-resolved contrast-enhanced magnetic resonance angiography in hypervascular spinal metastases prior embolization. Eur Radiol. 2021. PMID: 33449182. doi:10.1007/s00330-020-07654-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。